Skip to content
Inotiv Logo
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
  • Services
    • Discovery Through Approval
    • Computational Toxicology
    • Toxicogenomics
    • Genetic Toxicology
    • In Vivo Services
      • Safety Pharmacology
      • Developmental and Reproductive Toxicology
      • Surgical Models and Medical Device Testing
    • Pharmacology and Toxicology Assessment
    • Histology
    • Pathology
    • Bioanalytical Services
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
    • Drug Metabolism and Pharmacokinetics (DMPK)
    • List of Assays
    • Consulting
  • Insights
  • Contact
  • |
  • Investors
    • Press Room
    • Investor Information
    • SEC Filings
    • Corporate Governance
    • Investor Contacts
  • Careers
  • VISIT OUR VIRTUAL BOOTH

2022

Press Release

June 22, 2022

Glenn Washer Joins Inotiv, Inc., as Group President, Safety Assessment

Press Release

June 13, 2022

Inotiv, Inc. Announces Site Closures and Consolidation Plans

Corporate News

June 13, 2022

Inotiv Partners with Synexa Life Sciences to Establish Leading Global Provider of Full-spectrum, Preclinical and Clinical Biotherapeutics and Biomarker Analysis Solutions

Financial News

May 16, 2022

Inotiv, Inc. to Participate in Upcoming Investor Conferences

Press Release

May 12, 2022

Inotiv, Inc. Announces Second Quarter Fiscal 2022 Financial Results

Financial News

April 26, 2022

Inotiv, Inc. to Report Second Quarter Fiscal 2022 Financial Results and Host Conference Call on Thursday, May 12, 2022

Corporate News

April 25, 2022

Inotiv, Inc. Bolsters Pathology Services with Acquisition of Histion, LLC

Corporate News

April 11, 2022

Inotiv Welcomes Fernanda Beraldi as General Counsel and Corporate Secretary

Corporate News

February 22, 2022

Inotiv Welcomes Technology Veteran Mo Dastagir as Chief Technology Officer

Financial News

February 10, 2022

Inotiv, Inc. Announces First Quarter Fiscal 2022 Financial Results

Posts navigation

Older posts
Get the Insights You Deserve

Answering the right questions on time and with high-quality data is the key to achieving your objectives. Expect more.

Get In Touch
Inotiv Logo

2701 Kent Avenue
West Lafayette, IN 47906 USA
800.845.4246
765.463.4527

Copyright © 2022 Inotiv. All Rights Reserved.

  • Privacy
  • Accessibility
  • Terms Of Use
  • Contact
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
  • Services
    • Discovery Through Approval
    • Computational Toxicology
    • Toxicogenomics
    • Genetic Toxicology
    • In Vivo Services
      • Safety Pharmacology
      • Developmental and Reproductive Toxicology
      • Surgical Models and Medical Device Testing
    • Pharmacology and Toxicology Assessment
    • Histology
    • Pathology
    • Bioanalytical Services
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
    • Drug Metabolism and Pharmacokinetics (DMPK)
    • List of Assays
    • Consulting
  • Insights
  • Contact
  • |
  • Investors
    • Press Room
    • Investor Information
    • SEC Filings
    • Corporate Governance
    • Investor Contacts
  • Careers
  • VISIT OUR VIRTUAL BOOTH